Ultrasensitive immuno-detection using viral nanoparticles with modular assembly using genetically-directed biotinylation

Julia Litvinov, Anna E V Hagström, Yubitza Lopez, Meenu Adhikari, Katerina Kourentzi, Ulrich Strych, Federico A. Monzon, William Foster, Philip T. Cagle, Richard C. Willson

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We report a novel, modular approach to immuno-detection based on antibody recognition and PCR read-out that employs antibody-conjugated bacteriophage and easily-manipulated non-pathogenic viruses as affinity agents. Our platform employs phage genetically tagged for in vivo biotinylation during phage maturation that can easily be linked, through avidin, to any biotinylated affinity agent, including full-length antibodies, peptides, lectins or aptamers. The presence of analyte is reported with high sensitivity through real-time PCR. This approach avoids the need to clone antibody-encoding DNA fragments, allows the use of full-length, high affinity antibodies and, by having DNA reporters naturally encapsulated inside the bacteriophage, greatly reduces nonspecific binding of DNA. We validate the efficacy of this new approach through the detection of Vascular Endothelial Growth Factor, a known angiogenic cancer biomarker protein, at attomolar concentrations in bronchoalveolar lavage fluid.

Original languageEnglish (US)
Pages (from-to)1863-1868
Number of pages6
JournalBiotechnology Letters
Volume36
Issue number9
DOIs
StatePublished - 2014

Fingerprint

Biotinylation
Antibodies
Bacteriophages
Nanoparticles
DNA
Antibody Affinity
Avidin
Bronchoalveolar Lavage Fluid
Tumor Biomarkers
Lectins
Vascular Endothelial Growth Factor A
Real-Time Polymerase Chain Reaction
Viruses
Clone Cells
Peptides
Polymerase Chain Reaction
Proteins
Fluids

Keywords

  • Antibody recognition
  • Bacteriophage
  • Biomarker
  • Immuno-detection
  • Immuno-PCR
  • Immuno-phage assay
  • Vascular Endothelial Growth Factor

ASJC Scopus subject areas

  • Biotechnology
  • Medicine(all)

Cite this

Litvinov, J., Hagström, A. E. V., Lopez, Y., Adhikari, M., Kourentzi, K., Strych, U., ... Willson, R. C. (2014). Ultrasensitive immuno-detection using viral nanoparticles with modular assembly using genetically-directed biotinylation. Biotechnology Letters, 36(9), 1863-1868. https://doi.org/10.1007/s10529-014-1555-9

Ultrasensitive immuno-detection using viral nanoparticles with modular assembly using genetically-directed biotinylation. / Litvinov, Julia; Hagström, Anna E V; Lopez, Yubitza; Adhikari, Meenu; Kourentzi, Katerina; Strych, Ulrich; Monzon, Federico A.; Foster, William; Cagle, Philip T.; Willson, Richard C.

In: Biotechnology Letters, Vol. 36, No. 9, 2014, p. 1863-1868.

Research output: Contribution to journalArticle

Litvinov, J, Hagström, AEV, Lopez, Y, Adhikari, M, Kourentzi, K, Strych, U, Monzon, FA, Foster, W, Cagle, PT & Willson, RC 2014, 'Ultrasensitive immuno-detection using viral nanoparticles with modular assembly using genetically-directed biotinylation', Biotechnology Letters, vol. 36, no. 9, pp. 1863-1868. https://doi.org/10.1007/s10529-014-1555-9
Litvinov, Julia ; Hagström, Anna E V ; Lopez, Yubitza ; Adhikari, Meenu ; Kourentzi, Katerina ; Strych, Ulrich ; Monzon, Federico A. ; Foster, William ; Cagle, Philip T. ; Willson, Richard C. / Ultrasensitive immuno-detection using viral nanoparticles with modular assembly using genetically-directed biotinylation. In: Biotechnology Letters. 2014 ; Vol. 36, No. 9. pp. 1863-1868.
@article{fdf1764fe33448f68cb97338e61b37b9,
title = "Ultrasensitive immuno-detection using viral nanoparticles with modular assembly using genetically-directed biotinylation",
abstract = "We report a novel, modular approach to immuno-detection based on antibody recognition and PCR read-out that employs antibody-conjugated bacteriophage and easily-manipulated non-pathogenic viruses as affinity agents. Our platform employs phage genetically tagged for in vivo biotinylation during phage maturation that can easily be linked, through avidin, to any biotinylated affinity agent, including full-length antibodies, peptides, lectins or aptamers. The presence of analyte is reported with high sensitivity through real-time PCR. This approach avoids the need to clone antibody-encoding DNA fragments, allows the use of full-length, high affinity antibodies and, by having DNA reporters naturally encapsulated inside the bacteriophage, greatly reduces nonspecific binding of DNA. We validate the efficacy of this new approach through the detection of Vascular Endothelial Growth Factor, a known angiogenic cancer biomarker protein, at attomolar concentrations in bronchoalveolar lavage fluid.",
keywords = "Antibody recognition, Bacteriophage, Biomarker, Immuno-detection, Immuno-PCR, Immuno-phage assay, Vascular Endothelial Growth Factor",
author = "Julia Litvinov and Hagstr{\"o}m, {Anna E V} and Yubitza Lopez and Meenu Adhikari and Katerina Kourentzi and Ulrich Strych and Monzon, {Federico A.} and William Foster and Cagle, {Philip T.} and Willson, {Richard C.}",
year = "2014",
doi = "10.1007/s10529-014-1555-9",
language = "English (US)",
volume = "36",
pages = "1863--1868",
journal = "Biotechnology Letters",
issn = "0141-5492",
publisher = "Springer Netherlands",
number = "9",

}

TY - JOUR

T1 - Ultrasensitive immuno-detection using viral nanoparticles with modular assembly using genetically-directed biotinylation

AU - Litvinov, Julia

AU - Hagström, Anna E V

AU - Lopez, Yubitza

AU - Adhikari, Meenu

AU - Kourentzi, Katerina

AU - Strych, Ulrich

AU - Monzon, Federico A.

AU - Foster, William

AU - Cagle, Philip T.

AU - Willson, Richard C.

PY - 2014

Y1 - 2014

N2 - We report a novel, modular approach to immuno-detection based on antibody recognition and PCR read-out that employs antibody-conjugated bacteriophage and easily-manipulated non-pathogenic viruses as affinity agents. Our platform employs phage genetically tagged for in vivo biotinylation during phage maturation that can easily be linked, through avidin, to any biotinylated affinity agent, including full-length antibodies, peptides, lectins or aptamers. The presence of analyte is reported with high sensitivity through real-time PCR. This approach avoids the need to clone antibody-encoding DNA fragments, allows the use of full-length, high affinity antibodies and, by having DNA reporters naturally encapsulated inside the bacteriophage, greatly reduces nonspecific binding of DNA. We validate the efficacy of this new approach through the detection of Vascular Endothelial Growth Factor, a known angiogenic cancer biomarker protein, at attomolar concentrations in bronchoalveolar lavage fluid.

AB - We report a novel, modular approach to immuno-detection based on antibody recognition and PCR read-out that employs antibody-conjugated bacteriophage and easily-manipulated non-pathogenic viruses as affinity agents. Our platform employs phage genetically tagged for in vivo biotinylation during phage maturation that can easily be linked, through avidin, to any biotinylated affinity agent, including full-length antibodies, peptides, lectins or aptamers. The presence of analyte is reported with high sensitivity through real-time PCR. This approach avoids the need to clone antibody-encoding DNA fragments, allows the use of full-length, high affinity antibodies and, by having DNA reporters naturally encapsulated inside the bacteriophage, greatly reduces nonspecific binding of DNA. We validate the efficacy of this new approach through the detection of Vascular Endothelial Growth Factor, a known angiogenic cancer biomarker protein, at attomolar concentrations in bronchoalveolar lavage fluid.

KW - Antibody recognition

KW - Bacteriophage

KW - Biomarker

KW - Immuno-detection

KW - Immuno-PCR

KW - Immuno-phage assay

KW - Vascular Endothelial Growth Factor

UR - http://www.scopus.com/inward/record.url?scp=84905270732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905270732&partnerID=8YFLogxK

U2 - 10.1007/s10529-014-1555-9

DO - 10.1007/s10529-014-1555-9

M3 - Article

VL - 36

SP - 1863

EP - 1868

JO - Biotechnology Letters

JF - Biotechnology Letters

SN - 0141-5492

IS - 9

ER -